Scientific Opinions on Migraine - Zolmitriptan

Go to navigation
Go to content

Patient experience influences formulation preference: Results of three prospective studies with zolmitriptan

Primary care needs assessment for guidance on headache management

There is a strong unmet need for improved headache education among primary care physicians: results from a primary care needs assessment

Age-related trends and the placebo response rate in adolescent migraineurs

Patients who treat their migraine with zolmitriptan while the pain is still mild experience improved efficacy

Patient strategies for the management of migraine: interim results from an online market research study (MAZE Study phase IV)

Impact of migraine on sufferers and their families — MAZE* Study Phase III

What are patients looking for in a migraine therapy? – observations from the MAZE programme

Zolmitriptan conventional and orally disintegrating tablets achieve headache response as early as 30 minutes post-treatment: results of a pooled data analysis

Influence of baseline intensity of migraine and timing of drug administration on the efficacy of zolmitriptan oral tablet (2.5 and 5 mg)

Pages
1
2
Next

Not signed in

Page tools

Clinical Product Summary